Hard to Treat Diseases, Incorporated Announces: Oklahoma Hearing Results, Colorado Amended Complaint and Appeal Mediation Date
Friday November 11, 2:17 pm ET
DELRAY BEACH, FL--(MARKET WIRE)--Nov 11, 2005 -- Hard to Treat Diseases, Incorporated (HTTD) (Other OTC:HTDS.PK - News) announces the outcome of yesterday's hearing in Oklahoma. Shinn Capital withdrew its Motion for Default Judgment. Shinn Capital's Motion for Sanctions was stricken by the Court and while limited discovery is ongoing, the Court stated it will not include the production of any Tubercin to Shinn Capital.
HTTD filed its Amended Complaint as Intervenor regarding the replevin action in Colorado. The Amended Complaint can be viewed on the Company's website at: www.htdsotc.com . Click on Corporate, then click on Legal and the title is Denver Amended Complaint. Limited discovery is ongoing in Colorado.
Mediation is scheduled for Tuesday November 15, 2005 at 9:30 am with the U.S. Court of Appeals and the adversaries regarding the potential settlement of the appeal.
HTTD's CEO Colm King states, "HTTD will continue to protect the rights of its shareholders and keep them informed."
Cautionary Note Regarding Forward-Looking Statements
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this news release may contain or constitute forward-looking statements. These forward-looking statements are based on current expectations and are subject to risk and uncertainties. In connection with the "safe harbor" provisions of the Private Securities Litigation Act of 1995, Hard to Treat Diseases, Inc. provides the following cautionary statement identifying important factors which, among others, could cause the actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.
Contact:
CONTACT:
Colm J. King, CEO
Hard to Treat Diseases, Incorporated
(561) 278-7856
htdsotc.com |
